Cargando…
HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts
Niemann-Pick type C1 (NPC1) disease is a lysosomal lipid storage disorder caused by mutations of the NPC1 gene. More than 300 disease-associated mutations are reported in patients, resulting in abnormal accumulation of unesterified cholesterol, glycosphingolipids, and other lipids in late endosomes...
Autores principales: | Pipalia, Nina H., Saad, Syed Z., Subramanian, Kanagaraj, Cross, Abigail, al-Motawa, Aisha, Garg, Kunal, Blagg, Brian S.J., Neckers, Len, Helquist, Paul, Wiest, Olaf, Ory, Daniel S., Maxfield, Frederick R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517605/ https://www.ncbi.nlm.nih.gov/pubmed/34481829 http://dx.doi.org/10.1016/j.jlr.2021.100114 |
Ejemplares similares
-
Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of
Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts
por: Cruz, Dana L., et al.
Publicado: (2021) -
Therapeutic potential of histone deacetylase inhibitor for treatment of Niemann-Pick type C1 disease
por: Pipalia, Nina H, et al.
Publicado: (2014) -
Cholesterol Pathways Affected by Small Molecules That Decrease Sterol Levels in Niemann-Pick Type C Mutant Cells
por: Rujoi, Madalina, et al.
Publicado: (2010) -
Quantitative Comparison of the Efficacy of Various Compounds in Lowering Intracellular Cholesterol Levels in Niemann-Pick Type C Fibroblasts
por: Wehrmann, Zachary T., et al.
Publicado: (2012) -
Towards a New Diagnostic Standard for Niemann–Pick C Disease
por: Jiang, Xuntian, et al.
Publicado: (2016)